Fig. 4From: ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signalingEffects of paclitaxel, doxorubicin and gemcitabine treatment. Relative mRNA expression of ABCB1, ABCG2, ABCC1 and ABCC2 were studied following treatment of a) 3D co-culture aggregates of adenocarcinoma cell line A549 and NHLF; and b) 3D co-culture aggregates of squamous cell carcinoma cell line H520 and NHLF; with 100 nM paclitaxel, 100 nM doxorubicin, 100 nM gemcitabine for 48 h. mRNA expression was normalized to beta-actin. Data are presented as mean ± SEM, n = 3Back to article page